TABLE 3.
Clinical isolate | pI | MIC (μg/ml)
|
Penicillin G
|
Residual activity (%) | ||||
---|---|---|---|---|---|---|---|---|
Amoxicillin
|
Piperacillin
|
|||||||
Alone | With Caa | Alone | With Tazb | Km (μM) | Sp act (mU/mg) | |||
AP1 | 5.4 | 2,048 | 32 | 64 | 1 | 25 | 335 | 9.5 |
AP2 | 5.4 | >4,096 | 256 | 1,024 | 32 | 25 | 1,786 | 9.3 |
AP3 | 5.4 | 2,048 | 32 | 64 | 1 | 27 | 586 | 10 |
AP4 | 7.4 | 4,096 | 128 | 256 | 32 | 5 | 61 | NDc |
AP5 | 5.4 | 2,048 | 512 | 32 | 4 | 7 | 144 | 56 |
AP6 | 5.2 | 4,096 | 2,048 | 128 | 4 | 138 | 3,200 | 46.5 |
AP7 | 5.2 | 1,024 | 256 | 8 | 1 | 216 | 925 | 33 |
AP8 | 5.2 | 2,048 | 1,024 | 32 | 2 | 232 | 660 | 32.5 |
Ca, clavulanic acid at 2 μg/ml.
Taz, tazobactam at 4 μg/ml.
ND, not determined (the enzyme was unstable).